Literature DB >> 9192787

Apoptosis of late-stage erythroblasts in megaloblastic anemia: association with DNA damage and macrocyte production.

M J Koury1, D W Horne, Z A Brown, J A Pietenpol, B C Blount, B N Ames, R Hard, S T Koury.   

Abstract

An in vitro model of folate-deficient erythropoiesis has been developed using proerythroblasts isolated from the spleens of Friend virus-infected mice fed an amino acid-based, folate-free diet. Control proerythroblasts were obtained from Friend virus-infected mice fed the same diet plus 2 mg folic acid/kg diet. Our previous studies showed that, after 20 to 32 hours of culture in folate-deficient medium with 4 U/mL of erythropoietin, the folate-deficient proerythroblasts underwent apoptosis, whereas control erythroblasts survived and differentiated into reticulocytes over a period of 48 hours. The addition of folic acid or thymidine to the folate-deficient medium prevented the apoptosis of the folate-deficient erythroblasts, thereby implicating decreased thymidylate synthesis as the main cause of apoptosis in the folate-deficient erythroblasts. In the study reported here, we examined intracellular folate levels, uracil misincorporation into DNA, p53 and p21 proteins, and reticulocyte formation in erythroblasts cultured in folate-deficient or control medium. In all experiments, the folate-deficient erythroblasts cultured in folate-deficient medium gave results that varied significantly from folate-deficient erythroblasts cultured in control medium or control erythroblasts cultured in either folate-deficient or control media. Folate-deficient erythroblasts cultured in folate-deficient medium had marked decreases in all coenzyme forms of folate that persisted throughout culture, increased uracil misincorporation into DNA, persistent accumulations of p53 and p21, and decreased reticulocyte production but increased size of individual reticulocytes. A model of folate-deficient erythropoiesis based on apoptosis of late stage erythroblasts is presented. This model provides explanations for the clinical findings in megaloblastic anemia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192787

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Defective gene expression, S phase progression, and maturation during hematopoiesis in E2F1/E2F2 mutant mice.

Authors:  Feng X Li; Jing W Zhu; Christopher J Hogan; James DeGregori
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

2.  A Black Cohosh Extract Causes Hematologic and Biochemical Changes Consistent with a Functional Cobalamin Deficiency in Female B6C3F1/N Mice.

Authors:  Michelle C Cora; William Gwinn; Ralph Wilson; Debra King; Suramya Waidyanatha; Grace E Kissling; Sukhdev S Brar; Dorian Olivera; Chad Blystone; Greg Travlos
Journal:  Toxicol Pathol       Date:  2017-06-15       Impact factor: 1.902

3.  Cancer cells activate p53 in response to 10-formyltetrahydrofolate dehydrogenase expression.

Authors:  Natalia V Oleinik; Natalia I Krupenko; David G Priest; Sergey A Krupenko
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

4.  Nuclear substructure reorganization during late-stage erythropoiesis is selective and does not involve caspase cleavage of major nuclear substructural proteins.

Authors:  Sharon Wald Krauss; Annie J Lo; Sarah A Short; Mark J Koury; Narla Mohandas; Joel Anne Chasis
Journal:  Blood       Date:  2005-06-02       Impact factor: 22.113

5.  Folate, homocysteine and the ovarian cycle among healthy regularly menstruating women.

Authors:  Kara A Michels; Jean Wactawski-Wende; James L Mills; Karen C Schliep; Audrey J Gaskins; Edwina H Yeung; Keewan Kim; Torie C Plowden; Lindsey A Sjaarda; Ellen N Chaljub; Sunni L Mumford
Journal:  Hum Reprod       Date:  2017-08-01       Impact factor: 6.918

6.  An assay for uracil in human DNA at baseline: effect of marginal vitamin B6 deficiency.

Authors:  Susan T Mashiyama; Christine M Hansen; Esther Roitman; Stella Sarmiento; James E Leklem; Terry D Shultz; Bruce N Ames
Journal:  Anal Biochem       Date:  2007-09-01       Impact factor: 3.365

7.  Valproic acid increases expression of methylenetetrahydrofolate reductase (MTHFR) and induces lower teratogenicity in MTHFR deficiency.

Authors:  Marc Roy; Daniel Leclerc; Qing Wu; Sapna Gupta; Warren D Kruger; Rima Rozen
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429

8.  Metabolic derangement of methionine and folate metabolism in mice deficient in methionine synthase reductase.

Authors:  C Lee Elmore; Xuchu Wu; Daniel Leclerc; Erica D Watson; Teodoro Bottiglieri; Natalia I Krupenko; Sergey A Krupenko; James C Cross; Rima Rozen; Roy A Gravel; Rowena G Matthews
Journal:  Mol Genet Metab       Date:  2007-03-21       Impact factor: 4.797

9.  Moderate folate depletion modulates the expression of selected genes involved in cell cycle, intracellular signaling and folate uptake in human colonic epithelial cell lines.

Authors:  Jimmy W Crott; Zhenhua Liu; Mary K Keyes; Sang-Woon Choi; Hyeran Jang; Mary P Moyer; Joel B Mason
Journal:  J Nutr Biochem       Date:  2007-08-03       Impact factor: 6.048

Review 10.  The many flavors of hyperhomocyst(e)inemia: insights from transgenic and inhibitor-based mouse models of disrupted one-carbon metabolism.

Authors:  C Lee Elmore; Rowena G Matthews
Journal:  Antioxid Redox Signal       Date:  2007-11       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.